{"name":"Jin-Hee Ahn","slug":"jin-hee-ahn","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Trastuzumab biosimilar","genericName":"Trastuzumab biosimilar","slug":"trastuzumab-biosimilar","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Trastuzumab biosimilar","genericName":"Trastuzumab biosimilar","slug":"trastuzumab-biosimilar","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQa2MxdVl2bjIwSG94WVdlNHBqclJscHd4QVYtNFUzajFMYi16ZElLcTVEQURONzhaMVBhc1VsMGVqMUFuNjNZTGhtLW1BMXl0T1RsOU5pUHA0TXkxWUQ2OEtKWXRIOFZLZXA0dlJjSGJkNFdnYmhkZmoyXzBHWW01adIBlAFBVV95cUxQZzVxSGZxUE5ZcnZIa0Y4QXJrdk9WNGJSV21pOGhuNllSdDE1a2p0eUpUMEl1cG1ObExaNGJoU3drNmtvcGVMLVFHU09Gd01fSVd4eElIb1BodFQ0UXE1Nldsb3ZJQXJ6QXdELUx1dS1vSTk0QkowNC1YUmlMal9UY3RQa2x0TW1HNHRBcnJqa0d1aDVG?oc=5","date":"2025-12-14","type":"pipeline","source":"Chosunbiz","summary":"Korean pharma and biotech firms shift to co-CEO models and promote 30s executives - CHOSUNBIZ - Chosunbiz","headline":"Korean pharma and biotech firms shift to co-CEO models and promote 30s executives - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOVzM3ZkFGcXlCcUlzLWFoenRYSlRtRDlOVzUwRGROakRVQ09TUlNCTU83eDNBUWJ4MGRzNFJDeGdhYlFXVXhvRldCblg5WWs5Q2gxR2RDWG43b0EzV2k3ZEc1cGZNRTUySDVmczR2bS0yc3hHRUloVTFQZmtwQS1yQtIBlAFBVV95cUxOcWhYU3lYZ1NzTDRHazdoeVoxOGtQWkFvZDFvODBHN2NHMFY0SVd6SHQwWXNOVGVqcXg1b0VCYldCQVFvOHUtRTF4Xzk1T3otXzBDczVxZ1hPc0xkaVVnVHI5WXNnT2hMOUhneldlOTFnZExGTDNUNG5KaVVLdElkallkelYxWjBVcll2aVRlODZWcEVF?oc=5","date":"2025-05-28","type":"regulatory","source":"Chosunbiz","summary":"JD Bioscience gains FDA approval for phase 2a clinical trials on fatty liver drug - CHOSUNBIZ - Chosunbiz","headline":"JD Bioscience gains FDA approval for phase 2a clinical trials on fatty liver drug - CHOSUNBIZ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1NdGwwOWRRWmxPRE0yNnpTaWN5M3hPR09sWkRnUzFvdy1vVEF5YWJhbUhwWkN1OUdRR2l2MlZ3TVlZWmlxbEtXZ2ctY1lSX3FWdm1oNTZBSE9zU1JT?oc=5","date":"2024-04-03","type":"pipeline","source":"EurekAlert!","summary":"Gwangju Institute of Science and Technology researchers discover novel drug candidate to combat fatty liver disease - EurekAlert!","headline":"Gwangju Institute of Science and Technology researchers discover novel drug candidate to combat fatty liver disease - Eu","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}